正常组织并发症概率模型在临床中的应用。
Use of normal tissue complication probability models in the clinic.
机构信息
Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC 27514, USA.
出版信息
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S10-9. doi: 10.1016/j.ijrobp.2009.07.1754.
Abstract
The Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) review summarizes the currently available three-dimensional dose/volume/outcome data to update and refine the normal tissue dose/volume tolerance guidelines provided by the classic Emami et al. paper published in 1991. A "clinician's view" on using the QUANTEC information in a responsible manner is presented along with a description of the most commonly used normal tissue complication probability (NTCP) models. A summary of organ-specific dose/volume/outcome data, based on the QUANTEC reviews, is included.
摘要
《临床正常组织效应的定量分析》（QUANTEC）综述总结了目前可用的三维剂量/体积/结果数据，以更新和完善经典的 Emami 等人 1991 年发表的论文中提供的正常组织剂量/体积耐受指南。本文还介绍了一种“临床医生视角”，用于负责任地使用 QUANTEC 信息，并描述了最常用的正常组织并发症概率（NTCP）模型。根据 QUANTEC 综述，还包括了基于器官特异性剂量/体积/结果数据的总结。
相似文献
1
Use of normal tissue complication probability models in the clinic.正常组织并发症概率模型在临床中的应用。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S10-9. doi: 10.1016/j.ijrobp.2009.07.1754.
2
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues.临床正常组织效应的定量分析（QUANTEC）：科学问题简介。
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S3-9. doi: 10.1016/j.ijrobp.2009.09.040.
3
Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.基于 QUANTEC 报告发布之后的头颈部标准分割放射治疗相关正常组织并发症模型的系统评价
Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):391-407. doi: 10.1016/j.ijrobp.2017.09.041. Epub 2017 Sep 29.
4
[Probabilities of controlling tumors and complications (TCP/NTCP) after radiotherapy: methodologic, physical, and biological aspects].放疗后控制肿瘤和并发症的概率（TCP/NTCP）：方法学、物理学和生物学方面
Cancer Radiother. 2002 Nov;6 Suppl 1:155s-165s. doi: 10.1016/s1278-3218(02)00221-4.
5
TCP and NTCP in preclinical and clinical research in Europe.欧洲临床前和临床研究中的TCP与NTCP
Rays. 2005 Apr-Jun;30(2):121-6.
6
Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.前列腺癌外照射放疗后晚期直肠出血的正常组织并发症概率（NTCP）建模：对 QUANTEC 推荐的 NTCP 模型的检验。
Acta Oncol. 2010 Oct;49(7):1040-4. doi: 10.3109/0284186X.2010.509736.
7
Can dose-response models predict reliable normal tissue complication probabilities in radical radiotherapy of urinary bladder cancer? The impact of alternative radiation tolerance models and parameters.剂量反应模型能否预测膀胱癌根治性放疗中可靠的正常组织并发症概率？替代辐射耐受模型和参数的影响。
Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):627-37. doi: 10.1016/s0360-3016(01)01464-x.
8
Model-based calculation of thyroid gland normal tissue complication probability in head and neck cancer patients after radiation therapy.基于模型的头颈部癌症患者放疗后甲状腺正常组织并发症概率计算。
Strahlenther Onkol. 2020 Jun;196(6):561-568. doi: 10.1007/s00066-020-01579-y. Epub 2020 Feb 3.
9
Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis.多变量 NTCP 模型在放射性甲状腺功能减退症中的开发：对比分析。
Radiat Oncol. 2012 Dec 27;7:224. doi: 10.1186/1748-717X-7-224.
10
Application of Dempster-Shafer theory in dose response outcome analysis.Dempster-Shafer 理论在剂量反应结果分析中的应用。
Phys Med Biol. 2012 Sep 7;57(17):5575-85. doi: 10.1088/0031-9155/57/17/5575. Epub 2012 Aug 14.
引用本文的文献
1
Dosimetric and Radiobiological Comparison of Three-Dimensional Conformal Radiotherapy and Helical Tomotherapy in Whole Pelvic Radiotherapy of Prostate Cancer Patients.前列腺癌患者全盆腔放疗中三维适形放疗与螺旋断层放疗的剂量学和放射生物学比较
J Biomed Phys Eng. 2025 Aug 1;15(4):333-340. doi: 10.31661/jbpe.v0i0.2301-1587. eCollection 2025 Aug.
2
The Effects of Radiation Therapy on the Ocular Apparatus: Implications for Management.放射治疗对眼部器官的影响：管理启示
Cancers (Basel). 2025 Aug 8;17(16):2605. doi: 10.3390/cancers17162605.
3
Comparison of Quality of Life in Postoperative High-Grade Glioma Patients Treated Using EORTC and RTOG Target Delineation Techniques for Postoperative Radiotherapy.使用欧洲癌症研究与治疗组织（EORTC）和美国放射肿瘤学协作组（RTOG）术后放疗靶区勾画技术治疗的高级别胶质瘤患者术后生活质量比较
Asian J Neurosurg. 2025 Apr 21;20(3):506-513. doi: 10.1055/s-0045-1807761. eCollection 2025 Sep.
4
Comprehensive analysis of the role of deep inspiration breath-hold in right-sided breast cancer radiotherapy: A focus on cardiac substructures and right coronary artery.深吸气屏气在右侧乳腺癌放疗中作用的综合分析：聚焦心脏亚结构和右冠状动脉
J Appl Clin Med Phys. 2025 Sep;26(9):e70216. doi: 10.1002/acm2.70216.
5
Diversity and inclusivity in oncology: A narrative review and orientation for institutional measures in Germany.肿瘤学中的多样性与包容性：德国机构措施的叙述性综述与指南
Transl Oncol. 2025 Oct;60:102493. doi: 10.1016/j.tranon.2025.102493. Epub 2025 Aug 8.
6
Management of critically located brain metastases in patients with precluded survival using customised double-dose prescription-based, adaptive accelerated staged radiosurgery: a long-term retrospective analysis.使用基于定制双剂量处方的适应性加速分期放射外科治疗对生存受限患者的关键部位脑转移瘤进行管理：一项长期回顾性分析
Radiat Oncol. 2025 Aug 1;20(1):120. doi: 10.1186/s13014-025-02692-x.
7
Radiotherapy combined with anlotinib in locoregional recurrent esophageal squamous cell carcinoma after radical surgery: a prospective, Phase II clinical trial.放疗联合安罗替尼治疗根治性手术后局部区域复发的食管鳞状细胞癌：一项前瞻性II期临床试验。
Br J Cancer. 2025 Jul 16. doi: 10.1038/s41416-025-03101-6.
8
Uncertainties in outcome modelling in radiation oncology.放射肿瘤学中结果建模的不确定性。
Phys Imaging Radiat Oncol. 2025 May 7;34:100774. doi: 10.1016/j.phro.2025.100774. eCollection 2025 Apr.
9
Stereotactic body radiotherapy for unresectable or locally recurrent pancreatic cancer: A single centre experience.立体定向体部放疗用于不可切除或局部复发的胰腺癌：单中心经验
J Radiosurg SBRT. 2025;9(3):207-213.
10
Radio(chemo)therapy with curative intent for anal cancer - effectiveness and toxicity in elderly vs. younger patients.针对肛门癌的根治性放射（化学）治疗——老年患者与年轻患者的疗效和毒性对比
Front Oncol. 2025 May 16;15:1567655. doi: 10.3389/fonc.2025.1567655. eCollection 2025.
本文引用的文献
1
The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery.线性二次模型不适用于模拟放射外科中高单次剂量效应。
Semin Radiat Oncol. 2008 Oct;18(4):240-3. doi: 10.1016/j.semradonc.2008.04.005.
2
Value of whole brain re-irradiation for brain metastases--single centre experience.全脑再照射治疗脑转移瘤的价值——单中心经验
Clin Oncol (R Coll Radiol). 2007 Sep;19(7):532-8. doi: 10.1016/j.clon.2007.06.001. Epub 2007 Jul 26.
3
Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors.放疗结果的多变量建模，包括剂量体积和临床因素。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1275-86. doi: 10.1016/j.ijrobp.2005.11.022.
4
Orbital lymphoma: is it necessary to treat the entire orbit?眼眶淋巴瘤：是否有必要对整个眼眶进行治疗？
Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):527-30. doi: 10.1016/j.ijrobp.2004.03.039.
5
CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.《肿瘤治疗不良事件通用术语标准》第3.0版：癌症治疗不良反应综合分级系统的制定
Semin Radiat Oncol. 2003 Jul;13(3):176-81. doi: 10.1016/S1053-4296(03)00031-6.
6
Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop.辐射剂量-体积结果分析中的方法学问题：美国医学物理师协会/美国国立卫生研究院联合研讨会总结
Med Phys. 2002 Sep;29(9):2109-27. doi: 10.1118/1.1501473.
7
Modeling the effects of inhomogeneous dose distributions in normal tissues.模拟正常组织中不均匀剂量分布的影响。
Semin Radiat Oncol. 2001 Jul;11(3):197-209. doi: 10.1053/srao.2001.23478.
8
Clinical experience with retreatment for palliation.姑息性再治疗的临床经验。
Semin Radiat Oncol. 2000 Jul;10(3):210-21. doi: 10.1053/s1053-4296(00)80039-9.
9
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC).非小细胞肺癌（NSCLC）三维治疗后肺炎的临床剂量体积直方图分析
Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):323-9. doi: 10.1016/s0360-3016(99)00183-2.
10
A test of the claim that plan rankings are determined by relative complication and tumor-control probabilities.一项关于计划排名由相对并发症和肿瘤控制概率决定这一说法的检验。
Int J Radiat Oncol Biol Phys. 1998 May 1;41(2):451-7. doi: 10.1016/s0360-3016(98)00057-1.
Zotero 插件